Iterum Therapeutics plc

ITRM · Nasdaq · SIC 2834: Pharmaceutical Preparations
193
SEC Filings

Business Summary

PART I Item 1. B usiness. Overview We are a pharmaceutical company dedicated to maximizing the commercial potential of ORLYNVAH , the first oral branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Penems, including thiopenems and carbapenems, belong to a class of antibiotics more broadly defined as -lactam antibiotics, the original example of which was penicillin, but which now also includes cephalosporins. S...

Next Earnings

Q2 FY2026 — expected 2026-09-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionITRMdiscussed_in_filing Cybersecurity
topic_mentionITRMdiscussed_in_filing Cybersecurity
topic_mentionITRMdiscussed_in_filing Blockchain & Crypto
topic_mentionITRMdiscussed_in_filing Healthcare & Bio
topic_mentionITRMdiscussed_in_filing Blockchain & Crypto
topic_mentionITRMdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2025-02-072024-12-310000950170-25-015857EDGAR143K words
2024-03-282023-12-310000950170-24-037615EDGAR—
2023-03-162022-12-310000950170-23-008300EDGAR—
2022-03-282021-12-310001564590-22-011897EDGAR—
2021-03-122020-12-310001564590-21-012694EDGAR—
2020-03-122019-12-310001564590-20-010242EDGAR—
2019-03-252018-12-310001564590-19-009089EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001193125-25-281557EDGAR89K words
2025-08-052025-06-300000950170-25-102400EDGAR—
2025-05-132025-03-310000950170-25-069802EDGAR—
2024-11-142024-09-300000950170-24-126736EDGAR—
2024-08-142024-06-300000950170-24-096653EDGAR—
2024-05-132024-03-310000950170-24-058200EDGAR—
2023-11-142023-09-300000950170-23-063353EDGAR—
2023-08-112023-06-300000950170-23-041604EDGAR—
2023-05-122023-03-310000950170-23-021500EDGAR—
2022-11-102022-09-300000950170-22-024161EDGAR—
2022-08-122022-06-300000950170-22-017000EDGAR—
2022-05-132022-03-310000950170-22-009792EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001193125-26-133247EDGAR1K words
2026-03-270001193125-26-127785EDGAR—
2026-03-030001193125-26-088494EDGAR—
2026-03-020001193125-26-085646EDGAR—
2026-02-180001193125-26-057393EDGAR—
2025-12-120001193125-25-317728EDGAR—
2025-11-140001193125-25-281531EDGAR—
2025-10-160001193125-25-241556EDGAR—
2025-09-100000950170-25-113986EDGAR—
2025-08-280000950170-25-111974EDGAR—

193 total filings indexed. 164 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001659323
TickerITRM
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedL2

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 8c2e87947d4d881b88449e3ab907a646f27a6e3436e246c18280fced62e38999
parent: c07aded320a0eecbcfe696004379a3ff122f6ff3c840360fafe230174cd151b4
content hash: 8bd2509e562ec6db64d8f1d91cffc8ee188e98dc15f456748263c5b7f1d83c57
signed: 2026-04-13T04:45:46.286Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf